Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age-related diseases. It is developing a highly precise, patent-pending, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces the negative effects of aging pathologies and alsoextends the median lifespan and survival.Oisin Biotechnologies was founded in 2014 and is headquartered in Seattle, Washington.

Biotechnology

Health Care

Oisin Biotechnologies

Oisin Biotechnologies' headquarters in Seattle, WA, United States

Description

People (3)

Matthew Scholz

Eric Garcia

Stephen Hilbert

Jobs